Maravai LifeSciences seeks to raise $1.62B in IPO

 

• Maravai LifeSciences (MRVI) has priced its upsized IPO of 60M Class A common shares at $27.00/share, for gross proceeds of $1.62B.
• The Company initially planned to offer 50M shares at a range of $24 - $27.
• Trading kicks off today. Underwriters' over-allotment is an additional 9M shares.
• Morgan Stanley, Jefferies and Goldman are acting as joint book-running managers.
• Closing date is November 24.
• MRVI's products address customers’ needs for nucleic acid production, biologics safety testing and protein detection, and its operations are aligned to these three segments.
• https://seekingalpha.com/news/3638234-maravai-lifesciences-seeks-to-raise-1_62b-in-ipo